Global Pharmaceutical Grade Poloxamer 407 Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Pharmaceutical Grade Poloxamer 407 market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharmaceutical Grade Poloxamer 407 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharmaceutical Grade Poloxamer 407 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pharmaceutical Grade Poloxamer 407 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pharmaceutical Grade Poloxamer 407 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pharmaceutical Grade Poloxamer 407 include BASF, Croda, Comercial Química Massó, CD Formulation and Solvay, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the Pharmaceutical Grade Poloxamer 407 production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Pharmaceutical Grade Poloxamer 407 by region (region level and country level), by company, by type and by application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Pharmaceutical Grade Poloxamer 407, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pharmaceutical Grade Poloxamer 407, also provides the consumption of main regions and countries. Of the upcoming market potential for Pharmaceutical Grade Poloxamer 407, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Grade Poloxamer 407 sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharmaceutical Grade Poloxamer 407 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharmaceutical Grade Poloxamer 407 sales, projected growth trends, production technology, application and end-user industry.


Pharmaceutical Grade Poloxamer 407 Segment by Company

BASF
Croda
Comercial Química Massó
CD Formulation
Solvay

Pharmaceutical Grade Poloxamer 407 Segment by Type

Flakes
Powder

Pharmaceutical Grade Poloxamer 407 Segment by Application

Topical Formulations
Oral Care Formulations
Solid Dosage Forms

Pharmaceutical Grade Poloxamer 407 Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Poloxamer 407 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Poloxamer 407 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Poloxamer 407.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade Poloxamer 407 market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade Poloxamer 407 industry.
Chapter 3: Detailed analysis of Pharmaceutical Grade Poloxamer 407 market competition landscape. Including Pharmaceutical Grade Poloxamer 407 manufacturers' output value, output and average price from 2020 to 2025, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Pharmaceutical Grade Poloxamer 407 by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Pharmaceutical Grade Poloxamer 407 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pharmaceutical Grade Poloxamer 407 Production Value Estimates and Forecasts (2020-2031)
1.2.2 Global Pharmaceutical Grade Poloxamer 407 Production Capacity Estimates and Forecasts (2020-2031)
1.2.3 Global Pharmaceutical Grade Poloxamer 407 Production Estimates and Forecasts (2020-2031)
1.2.4 Global Pharmaceutical Grade Poloxamer 407 Market Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Global Pharmaceutical Grade Poloxamer 407 Market Dynamics
2.1 Pharmaceutical Grade Poloxamer 407 Industry Trends
2.2 Pharmaceutical Grade Poloxamer 407 Industry Drivers
2.3 Pharmaceutical Grade Poloxamer 407 Industry Opportunities and Challenges
2.4 Pharmaceutical Grade Poloxamer 407 Industry Restraints
3 Pharmaceutical Grade Poloxamer 407 Market by Manufacturers
3.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Manufacturers (2020-2025)
3.2 Global Pharmaceutical Grade Poloxamer 407 Production by Manufacturers (2020-2025)
3.3 Global Pharmaceutical Grade Poloxamer 407 Average Price by Manufacturers (2020-2025)
3.4 Global Pharmaceutical Grade Poloxamer 407 Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pharmaceutical Grade Poloxamer 407 Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pharmaceutical Grade Poloxamer 407 Manufacturers, Product Type & Application
3.7 Global Pharmaceutical Grade Poloxamer 407 Manufacturers Established Date
3.8 Market Competitive Analysis
3.8.1 Global Pharmaceutical Grade Poloxamer 407 Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pharmaceutical Grade Poloxamer 407 Players Market Share by Production Value in 2024
3.8.3 2024 Pharmaceutical Grade Poloxamer 407 Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade Poloxamer 407 Market by Type
4.1 Pharmaceutical Grade Poloxamer 407 Type Introduction
4.1.1 Flakes
4.1.2 Powder
4.2 Global Pharmaceutical Grade Poloxamer 407 Production by Type
4.2.1 Global Pharmaceutical Grade Poloxamer 407 Production by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical Grade Poloxamer 407 Production by Type (2020-2031)
4.2.3 Global Pharmaceutical Grade Poloxamer 407 Production Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Grade Poloxamer 407 Production Value by Type
4.3.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pharmaceutical Grade Poloxamer 407 Production Value by Type (2020-2031)
4.3.3 Global Pharmaceutical Grade Poloxamer 407 Production Value Market Share by Type (2020-2031)
5 Pharmaceutical Grade Poloxamer 407 Market by Application
5.1 Pharmaceutical Grade Poloxamer 407 Application Introduction
5.1.1 Topical Formulations
5.1.2 Oral Care Formulations
5.1.3 Solid Dosage Forms
5.2 Global Pharmaceutical Grade Poloxamer 407 Production by Application
5.2.1 Global Pharmaceutical Grade Poloxamer 407 Production by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pharmaceutical Grade Poloxamer 407 Production by Application (2020-2031)
5.2.3 Global Pharmaceutical Grade Poloxamer 407 Production Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Grade Poloxamer 407 Production Value by Application
5.3.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pharmaceutical Grade Poloxamer 407 Production Value by Application (2020-2031)
5.3.3 Global Pharmaceutical Grade Poloxamer 407 Production Value Market Share by Application (2020-2031)
6 Company Profiles
6.1 BASF
6.1.1 BASF Comapny Information
6.1.2 BASF Business Overview
6.1.3 BASF Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2020-2025)
6.1.4 BASF Pharmaceutical Grade Poloxamer 407 Product Portfolio
6.1.5 BASF Recent Developments
6.2 Croda
6.2.1 Croda Comapny Information
6.2.2 Croda Business Overview
6.2.3 Croda Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2020-2025)
6.2.4 Croda Pharmaceutical Grade Poloxamer 407 Product Portfolio
6.2.5 Croda Recent Developments
6.3 Comercial Química Massó
6.3.1 Comercial Química Massó Comapny Information
6.3.2 Comercial Química Massó Business Overview
6.3.3 Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2020-2025)
6.3.4 Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Product Portfolio
6.3.5 Comercial Química Massó Recent Developments
6.4 CD Formulation
6.4.1 CD Formulation Comapny Information
6.4.2 CD Formulation Business Overview
6.4.3 CD Formulation Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2020-2025)
6.4.4 CD Formulation Pharmaceutical Grade Poloxamer 407 Product Portfolio
6.4.5 CD Formulation Recent Developments
6.5 Solvay
6.5.1 Solvay Comapny Information
6.5.2 Solvay Business Overview
6.5.3 Solvay Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2020-2025)
6.5.4 Solvay Pharmaceutical Grade Poloxamer 407 Product Portfolio
6.5.5 Solvay Recent Developments
7 Global Pharmaceutical Grade Poloxamer 407 Production by Region
7.1 Global Pharmaceutical Grade Poloxamer 407 Production by Region: 2020 VS 2024 VS 2031
7.2 Global Pharmaceutical Grade Poloxamer 407 Production by Region (2020-2031)
7.2.1 Global Pharmaceutical Grade Poloxamer 407 Production by Region: 2020-2025
7.2.2 Global Pharmaceutical Grade Poloxamer 407 Production Forecast by Region: 2026-2031
7.3 Global Pharmaceutical Grade Poloxamer 407 Production by Region: 2020 VS 2024 VS 2031
7.4 Global Pharmaceutical Grade Poloxamer 407 Production Value by Region (2020-2031)
7.4.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Region: 2020-2025
7.4.2 Global Pharmaceutical Grade Poloxamer 407 Production Value by Region (2026-2031)
7.5 Global Pharmaceutical Grade Poloxamer 407 Market Price Analysis by Region (2020-2031)
7.6 Regional Production Value Trends (2020-2031)
7.6.1 North America Pharmaceutical Grade Poloxamer 407 Production Value (2020-2031)
7.6.2 Europe Pharmaceutical Grade Poloxamer 407 Production Value (2020-2031)
7.6.3 Asia-Pacific Pharmaceutical Grade Poloxamer 407 Production Value (2020-2031)
7.6.4 South America Pharmaceutical Grade Poloxamer 407 Production Value (2020-2031)
7.6.5 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Production Value (2020-2031)
8 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region
8.1 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region: 2020 VS 2024 VS 2031
8.2 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region (2020-2031)
8.2.1 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region (2020-2025)
8.2.2 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region (2026-2031)
8.3 North America
8.3.1 North America Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.3.2 North America Pharmaceutical Grade Poloxamer 407 Consumption by Country (2020-2031)
8.3.3 U.S.
8.3.4 Canada
8.3.5 Mexico
8.4 Europe
8.4.1 Europe Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.4.2 Europe Pharmaceutical Grade Poloxamer 407 Consumption by Country (2020-2031)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.5.2 Asia Pacific Pharmaceutical Grade Poloxamer 407 Consumption by Country (2020-2031)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 South America
8.6.1 South America Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.6.2 South America Pharmaceutical Grade Poloxamer 407 Consumption by Country (2020-2031)
8.6.3 Brazil
8.6.4 Argentina
8.6.5 Chile
8.6.6 Colombia
8.7 Middle East & Africa
8.7.1 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.7.2 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Consumption by Country (2020-2031)
8.7.3 Egypt
8.7.4 South Africa
8.7.5 Israel
8.7.6 Türkiye
8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
9.1 Pharmaceutical Grade Poloxamer 407 Value Chain Analysis
9.1.1 Pharmaceutical Grade Poloxamer 407 Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pharmaceutical Grade Poloxamer 407 Production Mode & Process
9.2 Pharmaceutical Grade Poloxamer 407 Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pharmaceutical Grade Poloxamer 407 Distributors
9.2.3 Pharmaceutical Grade Poloxamer 407 Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings